# Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

> **NCT03054337** · PHASE2 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 51 (actual)

## Conditions studied

- Anemia
- Non-dialysis Dependent Chronic Kidney Disease

## Interventions

- **DRUG:** Vadadustat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03054337
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-07-04
- **Final completion:** 2017-08-28
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03054337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03054337, "Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03054337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*